LUNG
Pulmonx Corporation
$1.26
-0.79%
2026-05-08
About Pulmonx Corporation
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Key Fundamentals
Forward P/E
-1.39
EPS (TTM)
$-1.30
ROE
-86.2%
Revenue Growth (YoY)
-8.7%
Profit Margin
-60.1%
Debt/Equity
123.02
Price/Book
1.14
Beta
0.18
Market Cap
$52.4M
Avg Volume (10D)
637K
Recent Breakout Signals
No recent breakout signals detected for LUNG.
Recent Price Range (60 Days)
60D High
$2.16
60D Low
$1.13
Avg Volume
530K
Latest Close
$1.26
Get breakout alerts for LUNG
Sign up for Breakout Scanner to receive daily notifications when LUNG triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Pulmonx Corporation (LUNG) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors LUNG daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. LUNG operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.